Thrombotic Thrombocytopenic Purpura

Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura

A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Longitudinal Cohort of Thrombosis and Hemostasis Diseases

Safety Study of Danazol With Plasma Exchange and Steroids for the Treatment of Thrombotic Thrombocytopenic Purpura (TTP)

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Study of Cyclosporine or Corticosteroids as an Adjunct to Plasma Exchange in Thrombotic Thrombocytopenic Purpura (TTP)

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Aspirin for Prophylaxis of TTP

.German TTP-Registry (Thrombotic Thrombocytopenic Purpura)

Magnesium Sulfate in Thrombotic Thrombocytopenic Purpura in Intensive Care

Low Dose Rituximab in Thrombotic Thrombocytopenic Purpura

The ConNeCT Study: Neurological Complications of TTP

Observational Study of the Use of octaplasLG®.

Romiplostim, Rituximab and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia

Octaplas Adult TTP Trial

Early Predictive Factors of Cardiac and Cerebral Involvement in TMA

The Role of Microparticles as a Biomarker

TTP and aHUS in Complicated Pregnancies